您的购物车当前为空
别名 4-(4,5-二氢-2-咪唑基)苯腈
SARS-CoV-2-IN-59(compound E07)为咪唑啉衍生物,其为一种针对SARS-CoV-2的非肽类小分子抑制剂,主要作用于冠状病毒的Mpro。SARS-CoV-2-IN-59于Mpro残基(Met 165, Gln 166,Met165, His 41, Gln 189)处展现出强烈的相互作用。

SARS-CoV-2-IN-59(compound E07)为咪唑啉衍生物,其为一种针对SARS-CoV-2的非肽类小分子抑制剂,主要作用于冠状病毒的Mpro。SARS-CoV-2-IN-59于Mpro残基(Met 165, Gln 166,Met165, His 41, Gln 189)处展现出强烈的相互作用。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | 待询 | 8-10周 | |
| 50 mg | 待询 | 8-10周 |
SARS-CoV-2-IN-59 相关产品
| 产品描述 | SARS-CoV-2-IN-59 (compound E07), an imidazoline derivative, is a non-peptide small molecule that inhibits SARS-CoV-2 by targeting its main protease (Mpro). It exhibits robust binding with Mpro residues (Met 165, Gln 166, Met 165, His 41, Gln 189) [1]. |
| 别名 | 4-(4,5-二氢-2-咪唑基)苯腈 |
| 分子量 | 171.2 |
| 分子式 | C10H9N3 |
| CAS No. | 850786-33-3 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容